Alector/$ALEC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Alector
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.
Ticker
$ALEC
Sector
Primary listing
Employees
103
Headquarters
Website
Alector Metrics
BasicAdvanced
$235m
-
-$1.19
0.65
-
Price and volume
Market cap
$235m
Beta
0.65
52-week high
$3.40
52-week low
$1.09
Average daily volume
509k
Financial strength
Current ratio
5.25
Quick ratio
5.041
Long term debt to equity
230.524
Total debt to equity
332.768
Profitability
EBITDA (TTM)
-127.494
Gross margin (TTM)
-482.51%
Net profit margin (TTM)
-680.83%
Operating margin (TTM)
-723.84%
Effective tax rate (TTM)
-0.13%
Revenue per employee (TTM)
$180,000
Management effectiveness
Return on assets (TTM)
-25.71%
Return on equity (TTM)
-238.85%
Valuation
Price to revenue (TTM)
12.178
Price to book
22.67
Price to tangible book (TTM)
22.67
Price to free cash flow (TTM)
-1.295
Free cash flow yield (TTM)
-77.22%
Free cash flow per share (TTM)
-1.637
Growth
Revenue change (TTM)
-79.15%
Earnings per share change (TTM)
-6.25%
3-year revenue growth (CAGR)
-47.28%
3-year earnings per share growth (CAGR)
-10.08%
What the Analysts think about Alector
Analyst ratings (Buy, Hold, Sell) for Alector stock.
Alector Financial Performance
Revenues and expenses
Alector Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Alector stock?
Alector (ALEC) has a market cap of $235M as of May 19, 2026.
What is the P/E ratio for Alector stock?
The price to earnings (P/E) ratio for Alector (ALEC) stock is 0 as of May 19, 2026.
Does Alector stock pay dividends?
No, Alector (ALEC) stock does not pay dividends to its shareholders as of May 19, 2026.
When is the next Alector dividend payment date?
Alector (ALEC) stock does not pay dividends to its shareholders.
What is the beta indicator for Alector?
Alector (ALEC) has a beta rating of 0.65. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.